Therapeutic effect of Ginsenoside Rb1 against mechanical trauma in rat model of postpartum stress urinary incontinence

Author:

Chen Shaohui1,Wei Bingyan1,Zhang Sanyuan2,Li Hongmei3,Huang Rui3

Affiliation:

1. Shanxi Medical University

2. First Hospital of Shanxi Medical University

3. Women Health Center of Shanxi and Children’s Hospital of Shanxi

Abstract

Abstract Stress urinary incontinence (SUI) was mainly caused by childbirth which injured the urethra and surrounding tissues’ structural integrity. Promoting periurethral structure repair and preventing its further damage had the potential to treat SUI. Ginsenoside Rb1(GS-Rb1) was one of the important monomer extracts of traditional Chinese medicine ginseng and notoginseng, which had anti-inflammatory, anti-oxidation, and promotion of tissue repair effects. In this study, we demonstrated the effects and the mechanism of GS-Rb1 on SUI induced by mechanical trauma by establishing of SUI rat model by vaginal distension(VD) method. We found that GS-Rb1 alleviated the symptoms associated with SUI and significantly decreased the number of fragmented and disorganized elastic and muscle fibers in the urethra and anterior vaginal wall of SUI rats, and increased collagen content, reduced the disruption of the structural integrity in the periurethral myofiber. Furthermore, GS-Rb1 promoted the expressions of TGF-β1, Smad2, Smad3, Smad7, p-Smad3, p-Smad2, collagens I and III, also increased the protein levels of Nrf2, GPX1, and MnSOD. Thus, our study identified that GS-Rb1 effectively reduced mechanical trauma to the urethral fibromuscular system in an SUI rat model. This study identifies GS-Rb1 as a TGF-β1/Smad3 and NRF2/ARE signaling pathway agonist and provides a potentially practical pharmacological approach for treating postpartum mechanical trauma SUI.

Publisher

Research Square Platform LLC

Reference32 articles.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3